Surovatamig as Consolidation Therapy in Participants With Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma With Unmutated Immunoglobulin Heavy Chain Variable (IGHV)

计划入组 420 人 · 首次发布于 2026 年 4 月 3 日

Genetic Test in Detecting Minimal Residual Disease in Samples From Younger Patients Registered on the COG-AALL08B1 Trial

计划入组 99 人 · 首次发布于 2012 年 6 月 28 日

Genetic Test To Identify Previously Undetectable Minimal Residual Disease in Cell Samples From Younger Patients With Acute Lymphoblastic Leukemia

计划入组 12 人 · 首次发布于 2012 年 2 月 15 日

Heavy Magnesium Carbounate

Libivirumab

Exbivirumab

Chain Drug Consortium

United States

SUMITOMO HEAVY INDUSTRIES, LTD.

Japan

Chain Drug Marketing Association, Inc.

United States

Invivoscribe Achieves IVDR Class C Certification for B-Cell Lymphoma Diagnostic Assay in Europe

Leveragen Secures Japanese Patent for Singularity Platform Single-Domain Antibody Discovery Technology

Biocytogen Secures Japan Patent for RenMab Platform, Strengthening Global IP Portfolio for Fully Human Antibody Discovery